HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary neuroendocrine carcinoma of the breast with leptomeninges metastasis: A case report and literature review.

Abstract
Primary neuroendocrine carcinoma of the breast (NECB) is a rare tumour with an incident rate of 0.3-0.5%. The most common metastatic sites of NECB are liver, bones, lung, pancreas, soft tissues and brain, while leptomeninges metastasis (LM) is reported rarely. This current case report describes a 50-year-old female patient with NECB and LM whose overall survival was 2 months. The report also presents the current literature regarding the knowledge of this unusual tumour and metastatic type. The current patient was diagnosed with NECB with right cerebellar metastasis, followed by LM. She underwent modified radical mastectomy of the left breast, left whole breast radiation therapy and incomplete adjuvant chemotherapy until the metastasis occurred. Whole-brain radiation therapy and a first-line salvage regimen of etoposide and cis-platinum were then undertaken. The patient died 2 months after their LM diagnosis. Primary NECB with LM is sporadic, devoid of effective treatment and associated with a poor prognosis. Consequently, it is vitally important to identify LM in order to achieve longer patient survival.
AuthorsMengqi Yuan, Dongmei Chen, Hongliang Sun, Xiuhong Wang, Donggui Wan
JournalThe Journal of international medical research (J Int Med Res) Vol. 50 Issue 9 Pg. 3000605221118505 (Sep 2022) ISSN: 1473-2300 [Electronic] England
PMID36069002 (Publication Type: Case Reports, Journal Article, Review)
Topics
  • Brain Neoplasms (surgery)
  • Breast Neoplasms (pathology)
  • Carcinoma, Neuroendocrine (pathology, therapy)
  • Cranial Irradiation
  • Female
  • Humans
  • Mastectomy
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: